ASX:AMT

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Allegra Orthopaedics

Executive Summary

Allegra Orthopaedics Limited designs, sells, and distributes orthopaedic implant products in Australia and New Zealand. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has Allegra Orthopaedics's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AMT is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 38% a week.

Volatility Over Time: AMT's weekly volatility has decreased from 99% to 38% over the past year, but is still higher than 75% of Australian stocks.


Market Performance


7 Day Return

-5.8%

AMT

2.7%

AU Medical Equipment

1.4%

AU Market


1 Year Return

n/a

AMT

-6.7%

AU Medical Equipment

-0.6%

AU Market

Return vs Industry: Insufficient data to determine how AMT performed against the Australian Medical Equipment industry.

Return vs Market: Insufficient data to determine how AMT performed against the Australian Market.


Shareholder returns

AMTIndustryMarket
7 Day-5.8%2.7%1.4%
30 Day-3.0%-2.2%3.0%
90 Day97.0%-5.8%11.9%
1 Yearn/a-5.5%-6.7%2.8%-0.6%
3 Year132.1%132.1%27.2%21.7%27.0%11.4%
5 Yearn/a94.1%80.1%68.6%34.6%

Long-Term Price Volatility Vs. Market

How volatile is Allegra Orthopaedics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Allegra Orthopaedics undervalued compared to its fair value and its price relative to the market?

7.12x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AMT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AMT is unprofitable, so we can't compare its PE Ratio to the AU Medical Equipment industry average.

PE vs Market: AMT is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AMT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AMT is overvalued based on its PB Ratio (7.1x) compared to the AU Medical Equipment industry average (7x).


Next Steps

Future Growth

How is Allegra Orthopaedics forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

31.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allegra Orthopaedics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Allegra Orthopaedics performed over the past 5 years?

7.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMT is currently unprofitable.

Growing Profit Margin: AMT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AMT is unprofitable, but has reduced losses over the past 5 years at a rate of 7.3% per year.

Accelerating Growth: Unable to compare AMT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AMT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (41.9%).


Return on Equity

High ROE: AMT has a negative Return on Equity (-25.65%), as it is currently unprofitable.


Next Steps

Financial Health

How is Allegra Orthopaedics's financial position?


Financial Position Analysis

Short Term Liabilities: AMT's short term assets (A$5.5M) exceed its short term liabilities (A$2.2M).

Long Term Liabilities: AMT's short term assets (A$5.5M) exceed its long term liabilities (A$74.6K).


Debt to Equity History and Analysis

Debt Level: AMT is debt free.

Reducing Debt: AMT currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AMT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: AMT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 33% each year


Next Steps

Dividend

What is Allegra Orthopaedics's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AMT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AMT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AMT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.0yrs

Average management tenure


CEO

Jenny Swain

4.67yrs

Tenure

AU$510,546

Compensation

Ms. Jenny Swain has been the Chief Executive Officer of Allegra Orthopaedics Limited since May 2, 2016. Ms. Swain served as Director Sales and Marketing of Allegra Orthopaedics Limited and served as its Na...


CEO Compensation Analysis

Compensation vs Market: Jenny's total compensation ($USD393.97K) is above average for companies of similar size in the Australian market ($USD293.77K).

Compensation vs Earnings: Jenny's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Jenny Swain
Chief Executive Officer4.67yrsAU$510.55k0.26%
A$ 86.8k
Justyn Stedwell
Company Secretary4yrsno datano data
Chris Calamos
Commercial & Finance Manager4yrsAU$128.83kno data

4.0yrs

Average Tenure

Experienced Management: AMT's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Anthony Hartnell
Non-Executive Director6.17yrsAU$46.07k0.54%
A$ 184.6k
Peter Kazacos
Non-Executive Chairman5.25yrsAU$63.59k0.11%
A$ 36.0k
Sean St Mulhearn
Non-Executive Director5.17yrsAU$46.07k0.70%
A$ 236.6k
Nicholas Hartnell
Non-Executive Director2.83yrsAU$45.00k1.16%
A$ 394.6k

5.2yrs

Average Tenure

66yo

Average Age

Experienced Board: AMT's board of directors are considered experienced (5.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: AMT insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.9%.


Top Shareholders

Company Information

Allegra Orthopaedics Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Allegra Orthopaedics Limited
  • Ticker: AMT
  • Exchange: ASX
  • Founded: 1994
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$33.949m
  • Shares outstanding: 104.46m
  • Website: https://www.allegraorthopaedics.com

Location

  • Allegra Orthopaedics Limited
  • 18-20 Orion Road
  • Level 8
  • Lane Cove West
  • New South Wales
  • 2066
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMTASX (Australian Securities Exchange)YesOrdinary SharesAUAUDDec 2007
AMTCHIA (Chi-X Australia)YesOrdinary SharesAUAUDDec 2007

Biography

Allegra Orthopaedics Limited designs, sells, and distributes orthopaedic implant products in Australia and New Zealand. The company operates through Orthopaedics Division and Innovation Division segments. ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/24 07:07
End of Day Share Price2021/01/22 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.